VIMBREXA
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Jan 2023)
What this means for you
This application is over — abandoned 23 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90271022
- Mark type
- Stylized text
- Filed
- 22 Oct 2020
- Published for opposition
- 27 Apr 2021
- Abandoned
- 23 Jan 2023
- Attorney of record
- Marie Lavalleye
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation for the treatment and management of neurological and musculoskeletal conditions, ailments and disorders; pharmaceutical preparations for the treatment and management of pain
Owner
- Primus Pharmaceuticals, Inc., Scottsdale, AZ, US
- Primus Pharmaceuticals, Inc., Scottsdale, AZ, US
Prosecution history
- 23 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Oct 2022 — ASSIGNED TO EXAMINER
- 22 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2022 — SOU EXTENSION 2 GRANTED
- 20 Apr 2022 — SOU EXTENSION 2 FILED
- 20 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2021 — SOU EXTENSION 1 GRANTED
- 22 Oct 2021 — SOU EXTENSION 1 FILED
- 22 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Jun 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Apr 2021 — PUBLISHED FOR OPPOSITION
- 07 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED